Sunitinib Malate Capsule
Product Images NDC 63304-094

9 FDA label images from Sun Pharmaceutical Industries Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sunitinib Malate (NDC 63304-094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-sunitinib-malate-structure (Spl Sunitinib Malate Structure)

Spl-sunitinib-malate-structure (Spl Sunitinib Malate Structure)
Chemical structure of sunitinib malate shown as a detailed 2D molecular diagram, displaying atoms including fluorine, carbon, nitrogen, oxygen, and hydrogen arranged to represent the full molecule.*
FDA Label Image

Spl-sunitinib-figure1 (Spl Sunitinib Figure1)

Spl-sunitinib-figure1 (Spl Sunitinib Figure1)
A Kaplan-Meier survival curve chart showing time to tumor progression in weeks for Sunitinib compared to placebo. The chart presents the probability of tumor progression over time, with Sunitinib showing a longer median time to progression than placebo.*
FDA Label Image

Spl-sunitinib-figure2 (Spl Sunitinib Figure2)

Spl-sunitinib-figure2 (Spl Sunitinib Figure2)
A Kaplan-Meier survival curve comparing progression-free survival probability (%) over time (weeks) between two groups: Sunitinib (N=375) with a median of 47.3 weeks and IFN-alpha (N=375) with a median of 22.0 weeks. The graph includes hazard ratio, confidence interval, p-value, and number of subjects at risk at various time points up to 60 weeks.*
FDA Label Image

Spl-sunitinib-figure3 (Spl Sunitinib Figure3)

Spl-sunitinib-figure3 (Spl Sunitinib Figure3)
A Kaplan-Meier survival curve chart comparing disease-free survival probability over time in years for two groups: Sunitinib (n=309) and Placebo (n=306). The chart shows survival probability on the y-axis and time in years on the x-axis, with Sunitinib demonstrating a median disease-free survival of 6.8 years and Placebo 5.6 years. The hazard ratio, confidence interval, and p-value are also displayed.*
FDA Label Image

Spl-sunitinib-figure4 (Spl Sunitinib Figure4)

Spl-sunitinib-figure4 (Spl Sunitinib Figure4)
A Kaplan-Meier survival curve chart depicting progression-free survival probability over time (months) for two groups: Sunitinib (N=86) and Placebo (N=85). The chart shows higher survival probability for the Sunitinib group, with median survival of 10.2 months compared to 5.4 months for Placebo. The hazard ratio is 0.427 with 95% confidence interval 0.271 to 0.673 and p-value 0.000146.*
FDA Label Image

12.5mg-28s (12.5mg 28s Label)

12.5mg-28s (12.5mg 28s Label)
Sunitinib Malate Capsules 12.5 mg label from Sun Pharmaceutical Industries Inc. The label includes dosage strength, pharmacist dispensing instructions, Rx only designation, and package count of 28 capsules. It provides storage and handling details, a barcode, and space for serialization on the right. The label is primarily white with purple accents and the Sun Pharma logo.*
FDA Label Image

25mg-28s (25mg 28s Label)

25mg-28s (25mg 28s Label)
Label for Sunitinib Malate Capsules, 25 mg strength, in an oral capsule dosage form. The label indicates the product is prescription-only with 28 capsules per container, produced by Sun Pharmaceutical Industries Inc. It includes storage instructions and a barcode, along with a note for pharmacists to dispense with the Medication Guide.*
FDA Label Image

37.5mg-28s (37.5mg 28s Label)

37.5mg-28s (37.5mg 28s Label)
Label for Sunitinib Malate Capsules 37.5 mg by Sun Pharmaceutical Industries Inc. The label shows the product name, strength (37.5 mg), quantity (28 capsules), dispensing instructions, storage conditions, manufacturer details, and a space for serialization. It includes a barcode and indicates the product is prescription only.*
FDA Label Image

50mg-28s (50mg 28s Label)

50mg-28s (50mg 28s Label)
Sunitinib Malate Capsules 50 mg package label from Sun Pharmaceutical Industries Inc. The label includes dosage information, pharmacist dispensing instructions, storage conditions, manufacturer details, and a barcode. The package contains 28 capsules for oral use and is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.